Logo image of ALNSE.PA

NSE (ALNSE.PA) Stock Fundamental Analysis

EPA:ALNSE - Euronext Paris - Matif - FR0004065639 - Common Stock - Currency: EUR

38  -0.8 (-2.06%)

Fundamental Rating

6

Overall ALNSE gets a fundamental rating of 6 out of 10. We evaluated ALNSE against 38 industry peers in the Aerospace & Defense industry. ALNSE gets an excellent profitability rating and is at the same time showing great financial health properties. ALNSE is not priced too expensively while it is growing strongly. Keep and eye on this one! This makes ALNSE very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

ALNSE had positive earnings in the past year.
In the past year ALNSE had a positive cash flow from operations.
ALNSE had positive earnings in each of the past 5 years.
ALNSE had a positive operating cash flow in 4 of the past 5 years.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M 15M

1.2 Ratios

ALNSE has a better Return On Assets (5.33%) than 86.84% of its industry peers.
Looking at the Return On Equity, with a value of 12.12%, ALNSE is in line with its industry, outperforming 52.63% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 11.21%, ALNSE belongs to the top of the industry, outperforming 81.58% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for ALNSE is in line with the industry average of 8.78%.
The 3 year average ROIC (9.55%) for ALNSE is below the current ROIC(11.21%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.33%
ROE 12.12%
ROIC 11.21%
ROA(3y)5.64%
ROA(5y)6.6%
ROE(3y)10.39%
ROE(5y)13.49%
ROIC(3y)9.55%
ROIC(5y)13.08%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 15 20

1.3 Margins

ALNSE has a Profit Margin of 5.12%. This is comparable to the rest of the industry: ALNSE outperforms 44.74% of its industry peers.
ALNSE's Profit Margin has improved in the last couple of years.
ALNSE has a Operating Margin (7.23%) which is in line with its industry peers.
In the last couple of years the Operating Margin of ALNSE has grown nicely.
ALNSE has a Gross Margin of 47.13%. This is in the better half of the industry: ALNSE outperforms 73.68% of its industry peers.
ALNSE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.23%
PM (TTM) 5.12%
GM 47.13%
OM growth 3Y-13.37%
OM growth 5Y28.55%
PM growth 3Y-1.49%
PM growth 5Y26.95%
GM growth 3Y-4.82%
GM growth 5Y-1.45%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), ALNSE is creating some value.
The number of shares outstanding for ALNSE remains at a similar level compared to 1 year ago.
The number of shares outstanding for ALNSE has been increased compared to 5 years ago.
ALNSE has a better debt/assets ratio than last year.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

2.2 Solvency

ALNSE has an Altman-Z score of 3.68. This indicates that ALNSE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of ALNSE (3.68) is better than 92.11% of its industry peers.
ALNSE has a debt to FCF ratio of 4.20. This is a neutral value as ALNSE would need 4.20 years to pay back of all of its debts.
ALNSE has a Debt to FCF ratio of 4.20. This is in the better half of the industry: ALNSE outperforms 71.05% of its industry peers.
A Debt/Equity ratio of 0.11 indicates that ALNSE is not too dependend on debt financing.
ALNSE has a Debt to Equity ratio of 0.11. This is amongst the best in the industry. ALNSE outperforms 94.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 4.2
Altman-Z 3.68
ROIC/WACC1.4
WACC8.03%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.64 indicates that ALNSE should not have too much problems paying its short term obligations.
The Current ratio of ALNSE (1.64) is better than 92.11% of its industry peers.
ALNSE has a Quick Ratio of 1.20. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
ALNSE has a Quick ratio of 1.20. This is amongst the best in the industry. ALNSE outperforms 89.47% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.2
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 41.04% over the past year.
ALNSE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 30.86% yearly.
The Revenue has grown by 40.14% in the past year. This is a very strong growth!
Measured over the past years, ALNSE shows a small growth in Revenue. The Revenue has been growing by 2.91% on average per year.
EPS 1Y (TTM)41.04%
EPS 3Y1.21%
EPS 5Y30.86%
EPS Q2Q%43.2%
Revenue 1Y (TTM)40.14%
Revenue growth 3Y3.03%
Revenue growth 5Y2.91%
Sales Q2Q%56.3%

3.2 Future

ALNSE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.03% yearly.
ALNSE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.56% yearly.
EPS Next Y11.92%
EPS Next 2Y27.42%
EPS Next 3Y15.03%
EPS Next 5YN/A
Revenue Next Year-7.68%
Revenue Next 2Y11.1%
Revenue Next 3Y8.56%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 24.36 indicates a rather expensive valuation of ALNSE.
Based on the Price/Earnings ratio, ALNSE is valued cheaper than 81.58% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 29.35. ALNSE is around the same levels.
With a Price/Forward Earnings ratio of 17.48, ALNSE is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALNSE indicates a rather cheap valuation: ALNSE is cheaper than 86.84% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ALNSE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 24.36
Fwd PE 17.48
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALNSE is valued cheaper than 86.84% of the companies in the same industry.
ALNSE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. ALNSE is more expensive than 68.42% of the companies in the same industry.
Industry RankSector Rank
P/FCF 79.98
EV/EBITDA 11.94
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ALNSE does not grow enough to justify the current Price/Earnings ratio.
ALNSE has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as ALNSE's earnings are expected to grow with 15.03% in the coming years.
PEG (NY)2.04
PEG (5Y)0.79
EPS Next 2Y27.42%
EPS Next 3Y15.03%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.64%, ALNSE is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 1.22, ALNSE is paying slightly less dividend.
With a Dividend Yield of 0.64, ALNSE pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years4
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 0.05 0.1 0.15 0.2

5.3 Sustainability

ALNSE pays out 17.01% of its income as dividend. This is a sustainable payout ratio.
DP17.01%
EPS Next 2Y27.42%
EPS Next 3Y15.03%
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

NSE

EPA:ALNSE (3/7/2025, 7:00:00 PM)

38

-0.8 (-2.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-14 2025-02-14/amc
Earnings (Next)N/A N/A
Inst Owners20.28%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap128.44M
Analysts40
Price Target29.78 (-21.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.22
Dividend Growth(5Y)N/A
DP17.01%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 24.36
Fwd PE 17.48
P/S 1.33
P/FCF 79.98
P/OCF 25.34
P/B 3.14
P/tB 3.53
EV/EBITDA 11.94
EPS(TTM)1.56
EY4.11%
EPS(NY)2.17
Fwd EY5.72%
FCF(TTM)0.48
FCFY1.25%
OCF(TTM)1.5
OCFY3.95%
SpS28.66
BVpS12.1
TBVpS10.76
PEG (NY)2.04
PEG (5Y)0.79
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 12.12%
ROCE 14.83%
ROIC 11.21%
ROICexc 13.71%
ROICexgc 15.54%
OM 7.23%
PM (TTM) 5.12%
GM 47.13%
FCFM 1.66%
ROA(3y)5.64%
ROA(5y)6.6%
ROE(3y)10.39%
ROE(5y)13.49%
ROIC(3y)9.55%
ROIC(5y)13.08%
ROICexc(3y)12.16%
ROICexc(5y)15.45%
ROICexgc(3y)13.89%
ROICexgc(5y)17.56%
ROCE(3y)12.64%
ROCE(5y)17.32%
ROICexcg growth 3Y-16.74%
ROICexcg growth 5Y23.86%
ROICexc growth 3Y-16.57%
ROICexc growth 5Y25.13%
OM growth 3Y-13.37%
OM growth 5Y28.55%
PM growth 3Y-1.49%
PM growth 5Y26.95%
GM growth 3Y-4.82%
GM growth 5Y-1.45%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF 4.2
Debt/EBITDA 0.45
Cap/Depr 102.34%
Cap/Sales 3.57%
Interest Coverage 18.38
Cash Conversion 48.81%
Profit Quality 32.4%
Current Ratio 1.64
Quick Ratio 1.2
Altman-Z 3.68
F-Score6
WACC8.03%
ROIC/WACC1.4
Cap/Depr(3y)117.56%
Cap/Depr(5y)91.66%
Cap/Sales(3y)4.35%
Cap/Sales(5y)3.55%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.04%
EPS 3Y1.21%
EPS 5Y30.86%
EPS Q2Q%43.2%
EPS Next Y11.92%
EPS Next 2Y27.42%
EPS Next 3Y15.03%
EPS Next 5YN/A
Revenue 1Y (TTM)40.14%
Revenue growth 3Y3.03%
Revenue growth 5Y2.91%
Sales Q2Q%56.3%
Revenue Next Year-7.68%
Revenue Next 2Y11.1%
Revenue Next 3Y8.56%
Revenue Next 5YN/A
EBIT growth 1Y25.65%
EBIT growth 3Y-10.75%
EBIT growth 5Y32.29%
EBIT Next Year20.39%
EBIT Next 3Y15.93%
EBIT Next 5YN/A
FCF growth 1Y-57.23%
FCF growth 3YN/A
FCF growth 5Y11.9%
OCF growth 1Y26.38%
OCF growth 3Y57.87%
OCF growth 5Y23.36%